healthcare - Page 2

Surprising Reaction to Lung Cancer Study Results

After Eli Lilly and Co. (NYSE: LLY) announced results from its midstage clinical trial for the treatment of lung cancer, its shares dipped on Monday. Specifically, these results come from ...
Read Full Story »

Why This New Dementia Study Is a Huge Hit

Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) shares rose sharply early Monday after the firm announced that its late-stage dementia study met its primary endpoint. Specifically, the results come from Acadia’s Phase ...
Read Full Story »

New Cellulite Study Submission Could Be a Big Hit

Endo International PLC (NASDAQ: ENDP) shares jumped on Friday after the company announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) ...
Read Full Story »

Why This Analyst Sees Cidara Nearly Doubling

Earlier this week, Cidara Therapeutics Inc. (NASDAQ: CDTX) announced a huge deal that catapulted the stock up nearly 50%. While this seems to be the big break Cidara needs, speaking ...
Read Full Story »

Breakthrough Sickle Cell Disease Treatment Is on the Way

Global Blood Therapeutics Inc. (NASDAQ: GBT) shares jumped on Thursday after the company announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the company’s New Drug ...
Read Full Story »

What This Recent FDA Move Could Mean for Breast Cancer Patients With Brain Metastases

Puma Biotechnology Inc. (NASDAQ: PBYI) shares jumped early Wednesday after the announcement that the U.S. Food and Drug Administration (FDA) provided an update on the company’s breast cancer treatment. However, ...
Read Full Story »

What Ardelyx’s Successful Hyperphosphatemia Study Means for CKD Patients

Ardelyx Inc. (NASDAQ: ARDX) shares jumped on Tuesday after the firm announced positive results from its late-stage study in dialysis patients who have uncontrolled hyperphosphatemia. Specifically, this was the Phase ...
Read Full Story »

Here’s the Big Break for Cidara’s Fungal Infection Study

Cidara Therapeutics Inc. (NASDAQ: CDTX) shares saw a massive gain on Tuesday after the firm announced that it has entered into a strategic partnership with Mundipharma. The goal of this ...
Read Full Story »

Why This Late-Stage LDL-Cholesterol Study Could Be a Big Hit

The Medicines Co. (NASDAQ: MDCO) shares made a handy gain on Tuesday after the firm announced results from its late-stage trial in the treatment of low-density lipoprotein cholesterol (LDL-C). Specifically, ...
Read Full Story »

Cannabis Stocks See Even Higher Levels of Short Interest

Cannabis stocks had a huge showing on Wall Street last fall. In fact, most of the news flow surrounding these stocks had investors pouring money into them. Some of the ...
Read Full Story »

Short Sellers Hike Their Bets in Biotech

The short interest data are out for the most recent settlement date, August 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Big Pharma Sees a Rising Tide in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Baird Health Care and Biotech Picks Have Massive Upside Potential

The more disruptive the market is, the more we look for companies that are not affected by the daily sturm and drang of the news cycle because they have supply ...
Read Full Story »

Is Amgen Overpaying for Celgene’s Psoriasis Treatment?

Both Amgen Inc. (NASDAQ: AMGN) and Celgene Corp. (NASDAQ: CELG) shares made a handy gain on Monday after it was announced that the companies had made an agreement in relation ...
Read Full Story »

What This Cholesterol Study Means Going Forward

The Medicines Co. (NASDAQ: MDCO) shares jumped early on Monday after the firm announced results from its late-stage cholesterol study. Specifically, it reported results from its Phase 3 study of ...
Read Full Story »